These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 16680230

  • 1. The effect of interferon alpha plus ribavirin on health-related quality of life in chronic C hepatitis. The Romanian experience.
    Pojoga C, Dumitraşcu DL, Pascu O, Grigorescu M.
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):31-5. PubMed ID: 16680230
    [Abstract] [Full Text] [Related]

  • 2. State of the iron metabolism in patients with chronic hepatitis C type C does not influence antiviral treatment with interferon and ribavirin.
    Jurczyk K, Karpińska E, Wawrzynowicz-Syczewska M, Morańska I, Noceń I, Chlubek D, Boroń-Kaczmarska A.
    Hepatogastroenterology; 2008 Mar; 55(82-83):557-61. PubMed ID: 18613407
    [Abstract] [Full Text] [Related]

  • 3. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK, Bansal SB, Gupta A, Gulati S, Kumar A, Prasad N.
    Clin Transplant; 2006 Mar; 20(6):677-83. PubMed ID: 17100715
    [Abstract] [Full Text] [Related]

  • 4. High-dose vitamin E supplementation does not diminish ribavirin-associated haemolysis in hepatitis C treatment with combination standard alpha-interferon and ribavirin.
    Saeian K, Bajaj JS, Franco J, Knox JF, Daniel J, Peine C, McKee D, Varma RR, Ho S, Midwest Hepatitis Study Group.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1189-93. PubMed ID: 15569122
    [Abstract] [Full Text] [Related]

  • 5. [Changes in socio-economics, quality of life and knowledge of patients with chronic hepatitis C during the Hepatitis Competence Net Project].
    Niederau C, Bemba G, Kautz A.
    Z Gastroenterol; 2008 Jan 15; 46(1):22-33. PubMed ID: 18188813
    [Abstract] [Full Text] [Related]

  • 6. Sustained responders have better quality of life and productivity compared with treatment failures long after antiviral therapy for hepatitis C.
    John-Baptiste AA, Tomlinson G, Hsu PC, Krajden M, Heathcote EJ, Laporte A, Yoshida EM, Anderson FH, Krahn MD.
    Am J Gastroenterol; 2009 Oct 15; 104(10):2439-48. PubMed ID: 19568230
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of ribavirin plus interferon-alpha in patients aged >or=60 years with chronic hepatitis C.
    Honda T, Katano Y, Urano F, Murayama M, Hayashi K, Ishigami M, Nakano I, Yoshioka K, Toyoda H, Kumada T, Goto H.
    J Gastroenterol Hepatol; 2007 Jul 15; 22(7):989-95. PubMed ID: 17608843
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Treatment of chronic hepatitis C with interferon alpha and ribavirin. Results in "real life"].
    Pariente A, Djilloul A, Cadranel JF, Association Nationale des Gastroentérologues des Hôpitaux Généraux.
    Gastroenterol Clin Biol; 2003 Jun 15; 27(6-7):590-5. PubMed ID: 12910222
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A 24-week course of high-dose interferon-alpha plus ribavirin for Taiwanese chronic hepatitis C patients with persistently normal or near-normal alanine aminotransferase levels.
    Yu ML, Dai CY, Lee LP, Hou NJ, Hsieh MY, Huang JF, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL.
    Liver Int; 2006 Dec 15; 26(10):1187-95. PubMed ID: 17105583
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Vogt-Koyanagi-Harada disease associated with interferon-A and ribavirin therapy for chronic hepatitis C infection.
    Papastathopoulos K, Bouzas E, Naoum G, Vergados I, Tsiodras S.
    J Infect; 2006 Feb 15; 52(2):e59-61. PubMed ID: 15951019
    [Abstract] [Full Text] [Related]

  • 20. Frequency of depression and somatic symptoms in patients on interferon alpha/ribavirin for chronic hepatitis C.
    Shakoor A, Shafqat F, Mehmud Te, Akram M, Riaz S, Iqbal Z, Khan AA.
    J Ayub Med Coll Abbottabad; 2010 Feb 15; 22(4):6-9. PubMed ID: 22455250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.